Bankole, O.;                     Scambi, I.;                     Parrella, E.;                     Muccilli, M.;                     Bonafede, R.;                     Turano, E.;                     Pizzi, M.;                     Mariotti, R.    
        Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice. Int. J. Mol. Sci. 2022, 23, 1047.
    https://doi.org/10.3390/ijms23031047
    AMA Style
    
                                Bankole O,                                 Scambi I,                                 Parrella E,                                 Muccilli M,                                 Bonafede R,                                 Turano E,                                 Pizzi M,                                 Mariotti R.        
                Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice. International Journal of Molecular Sciences. 2022; 23(3):1047.
        https://doi.org/10.3390/ijms23031047
    
    Chicago/Turabian Style
    
                                Bankole, Oluwamolakun,                                 Ilaria Scambi,                                 Edoardo Parrella,                                 Matilde Muccilli,                                 Roberta Bonafede,                                 Ermanna Turano,                                 Marina Pizzi,                                 and Raffaella Mariotti.        
                2022. "Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice" International Journal of Molecular Sciences 23, no. 3: 1047.
        https://doi.org/10.3390/ijms23031047
    
    APA Style
    
                                Bankole, O.,                                 Scambi, I.,                                 Parrella, E.,                                 Muccilli, M.,                                 Bonafede, R.,                                 Turano, E.,                                 Pizzi, M.,                                 & Mariotti, R.        
        
        (2022). Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice. International Journal of Molecular Sciences, 23(3), 1047.
        https://doi.org/10.3390/ijms23031047